blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3600253

EP3600253 - LIPOSOMAL COMPOSITIONS AND SOLID ORAL DOSAGE FORMS COMPRISING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.01.2023
Database last updated on 06.07.2024
FormerThe patent has been granted
Status updated on  11.02.2022
FormerGrant of patent is intended
Status updated on  21.10.2021
FormerRequest for examination was made
Status updated on  14.09.2021
FormerGrant of patent is intended
Status updated on  29.04.2021
FormerRequest for examination was made
Status updated on  03.01.2020
FormerThe international publication has been made
Status updated on  06.10.2018
Formerunknown
Status updated on  13.04.2018
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024 [2024/29]
Applicant(s)For all designated states
Universität Heidelberg
Grabengasse 1
69117 Heidelberg / DE
[2020/06]
Inventor(s)01 / UHL, Philipp
Obere Seegasse 42
69124 Heidelberg / DE
02 / SAUTER, Max
Cambridgestrasse 3
69115 Heidelberg / DE
03 / MIER, Walter
Brückweg 21
64625 Bensheim / DE
 [2020/06]
Representative(s)Fuchs Patentanwälte Partnerschaft mbB
Tower 185
Friedrich-Ebert-Anlage 35-37
60327 Frankfurt am Main / DE
[N/P]
Former [2020/06]Fuchs Patentanwälte Partnerschaft mbB
Westhafenplatz 1
60327 Frankfurt am Main / DE
Application number, filing date18714527.103.04.2018
[2020/06]
WO2018EP58464
Priority number, dateEP2017000053630.03.2017         Original published format: EP 17000536
[2020/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018178395
Date:04.10.2018
Language:EN
[2018/40]
Type: A1 Application with search report 
No.:EP3600253
Date:05.02.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 04.10.2018 takes the place of the publication of the European patent application.
[2020/06]
Type: B1 Patent specification 
No.:EP3600253
Date:16.03.2022
Language:EN
[2022/11]
Search report(s)International search report - published on:EP04.10.2018
ClassificationIPC:A61K9/127, A61K9/28, A61K9/48, C07K7/64
[2020/06]
CPC:
A61K9/1271 (EP,US); A61K38/12 (RU); A61K47/44 (RU);
A61K9/127 (RU); A61K9/28 (RU,US); A61K9/2846 (EP,RU);
A61K9/4891 (EP,RU,US); C07K16/241 (US); C07K7/64 (EP,RU);
C07K2317/21 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/06]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:LIPOSOMALE ZUSAMMENSETZUNGEN UND FESTSTOFFDOSIERUNGSFORMEN DAMIT[2021/17]
English:LIPOSOMAL COMPOSITIONS AND SOLID ORAL DOSAGE FORMS COMPRISING THE SAME[2020/06]
French:COMPOSITIONS LIPOSOMALES ET FORMES POSOLOGIQUES SOLIDES LES COMPRENANT[2021/17]
Former [2020/06]LIPOSOMALE ZUSAMMENSETZUNGEN UND DIESELBEN UMFASSENDE FESTE DARREICHUNGSFORMEN
Former [2020/06]COMPOSITIONS LIPOSOMALES ET FORMES PHARMACEUTIQUES ORALES SOLIDES COMPRENANT CELLES-CI
Entry into regional phase28.10.2019National basic fee paid 
28.10.2019Designation fee(s) paid 
28.10.2019Examination fee paid 
Examination procedure28.10.2019Examination requested  [2020/06]
28.10.2019Date on which the examining division has become responsible
19.05.2020Amendment by applicant (claims and/or description)
30.04.2021Communication of intention to grant the patent
10.09.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.09.2021Fee for grant paid
10.09.2021Fee for publishing/printing paid
21.10.2021Communication of intention to grant the patent
03.02.2022Receipt of the translation of the claim(s)
Opposition(s)19.12.2022No opposition filed within time limit [2023/08]
Fees paidRenewal fee
22.04.2020Renewal fee patent year 03
22.04.2021Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.04.2018
AL16.03.2022
AT16.03.2022
CY16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
MK16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
TR16.03.2022
IE03.04.2022
LU03.04.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
[2024/29]
Former [2024/24]HU03.04.2018
AL16.03.2022
AT16.03.2022
CY16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
MK16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
IE03.04.2022
LU03.04.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2024/23]AL16.03.2022
AT16.03.2022
CY16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
MK16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
IE03.04.2022
LU03.04.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2024/20]AL16.03.2022
AT16.03.2022
CY16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
IE03.04.2022
LU03.04.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/20]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
IE03.04.2022
LU03.04.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/10]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SI16.03.2022
SK16.03.2022
SM16.03.2022
LU03.04.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/08]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
LU03.04.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/07]AL16.03.2022
AT16.03.2022
CZ16.03.2022
DK16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/06]AL16.03.2022
AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
MC16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2023/01]AL16.03.2022
AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2022/51]AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
IS16.07.2022
PT18.07.2022
Former [2022/50]AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
PL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
PT18.07.2022
Former [2022/49]AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SK16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
PT18.07.2022
Former [2022/48]AT16.03.2022
CZ16.03.2022
EE16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
PT18.07.2022
Former [2022/47]AT16.03.2022
FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
RO16.03.2022
RS16.03.2022
SE16.03.2022
SM16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
PT18.07.2022
Former [2022/44]FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
NL16.03.2022
RS16.03.2022
SE16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
Former [2022/39]FI16.03.2022
HR16.03.2022
LT16.03.2022
LV16.03.2022
RS16.03.2022
SE16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
Former [2022/36]HR16.03.2022
LT16.03.2022
LV16.03.2022
RS16.03.2022
SE16.03.2022
BG16.06.2022
NO16.06.2022
GR17.06.2022
Former [2022/35]HR16.03.2022
LT16.03.2022
RS16.03.2022
SE16.03.2022
BG16.06.2022
NO16.06.2022
Former [2022/33]LT16.03.2022
NO16.06.2022
Cited inInternational search[A]CN103417480  (UNIV SICHUAN) [A] 1-12* example - *;
 [A]US2016106864  (LIM HYUNG JUN [KR], et al) [A] 1-12 * paragraph [0077] - paragraph [0081]; claim 11 *;
 [Y]  - SILVIA F. PANTZE ET AL, "Matrix liposomes: A solid liposomal formulation for oral administration : Solid liposomes for oral administration", EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY., DE, (201409), vol. 116, no. 9, doi:10.1002/ejlt.201300409, ISSN 1438-7697, pages 1145 - 1154, XP055407942 [Y] 1-12 * the whole document * * page 1146, column L, line 25 - line 30 *

DOI:   http://dx.doi.org/10.1002/ejlt.201300409
 [Y]  - ZHANG DONGDONG ET AL, "Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems", JOURNAL OF CONTROLLED RELEASE, (20160316), vol. 229, doi:10.1016/J.JCONREL.2016.03.020, ISSN 0168-3659, pages 130 - 139, XP029521834 [Y] 1-12 * page 133, column L, paragraph L *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2016.03.020
 [Y]  - BASHYAL SANTOSH ET AL, "Cell penetrating peptides as an innovative approach for drug delivery; then, present and the future", JOURNAL OF KOREAN PHARMACEUTICAL SCIENCES, KOREAN SOCIETY OF PHARMACEUTICAL SCIENCES AND TECHNOLOGY, KOREA, vol. 46, no. 3, doi:10.1007/S40005-016-0253-0, ISSN 2093-5552, (20160507), pages 205 - 220, (20160507), XP035971922 [Y] 1-12 * page 211, column L, paragraph L *

DOI:   http://dx.doi.org/10.1007/s40005-016-0253-0
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.